Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Larazotide acetate in celiac disease during gluten challenge
NCT00362856Phase 2Completed
- Sponsor
- Innovate Biopharmaceuticals
- Start
- Sep 2006
- Primary completion
- Mar 2007
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of larazotide in celiac disease, sponsored by Innovate Biopharmaceuticals. Started Sep 2006; status: completed.
02
Drugs
larazotide
03
Conditions
celiac disease
Beyond the preview
Go deeper on NCT00362856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00362856.